Sølling, A.S. http://orcid.org/0000-0001-7252-8128
Christensen, D.H. http://orcid.org/0000-0002-2693-5651
Darvalics, B.
Harsløf, T. http://orcid.org/0000-0002-8581-3523
Thomsen, R.W. http://orcid.org/0000-0001-9135-3474
Langdahl, B. http://orcid.org/0000-0002-8712-7199
Funding for this research was provided by:
Sundhedsvidenskabelige Fakultet, Aarhus Universitet
The Research Foundation of the Department of Endocrinology and Internal Medicine and the Department of Clinical Epidemiology, Aarhus University Hospital
Article History
Received: 26 August 2020
Accepted: 13 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: Anne Sophie Sølling has nothing to disclose.Diana Hedevang Christensen has nothing to disclose.Bianka Darvalics has nothing to disclose.Torben Harsløf received lecture fees from Amgen, Astra Zeneca, and Eli Lilly.Reimar Wernich Thomsen has nothing to disclose.Bente Langdahl is an editor-in-chief of Bone Reports and an associate editor of the <i>European Journal of Endocrinology</i> and has received research funding to her institution from Amgen and Novo Nordisk. Bente Langdahl serves on advisory boards and speaker’s bureau for Amgen, Eli Lilly, Gedeon-Richter, Gilead, and UCB.The Department of Clinical Epidemiology is involved in studies of osteoporosis with funding from various companies as research grants to (and administered by) Aarhus University.
: The Research Foundation was not involved in the conduct of the study, data collection, interpretation of the data, or the preparation of the manuscript.
: Please see supplementary Table InternalRef removed for International Classification of Diseases, Tenth Revision codes, procedure and NOMESCO surgery codes, and Anatomical Therapeutic Chemical classification system codes used in this study.